Literature DB >> 17255316

Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes.

Catherine A Lázaro1, Ming Chang, Weiliang Tang, Jean Campbell, Daniel G Sullivan, David R Gretch, Lawrence Corey, Robert W Coombs, Nelson Fausto.   

Abstract

Understanding the pathogenesis of hepatitis C requires the availability of tissue culture models that sustain viral replication and produce infectious particles. We report on the establishment of a culture system of nontransformed human fetal hepatocytes that supports hepatitis C virus (HCV) replication after transfection with full-length in vitro-transcribed genotype 1a HCV RNA without adaptive mutations and infection with patient sera of diverse HCV genotypes. Transfected and infected hepatocytes expressed HCV core protein and HCV negative-strand RNA. For at least 2 months, transfected or infected cultures released HCV into the medium at high levels and usually with a cyclical pattern. Viral replication had some cytotoxic effects on the cells, which produced interferon (IFN)-beta as a component of the antiviral response. Medium from transfected cells was able to infect naïve cultures in a Transwell system, and the infection was blocked by IFN-alpha and IFN-lambda. Viral particles analyzed by sucrose density centrifugation had a density of 1.17 g/ml. Immunogold labeling with antibody against HCV envelope protein E2 decorated the surface of the viral particles, as visualized by electron microscopy. This culture system may be used to study the responses of nontransformed human hepatocytes to HCV infection, to analyze serum infectivity, and to clone novel HCVs from infected patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255316      PMCID: PMC1851861          DOI: 10.2353/ajpath.2007.060789

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

Review 1.  Systems to culture hepatitis C virus.

Authors:  N Kato; K Shimotohno
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

2.  Epidemiology of hepatitis C in the United States.

Authors:  I Williams
Journal:  Am J Med       Date:  1999-12-27       Impact factor: 4.965

3.  Natural history of hepatitis C.

Authors:  L B Seeff
Journal:  Am J Med       Date:  1999-12-27       Impact factor: 4.965

4.  In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease.

Authors:  M Chang; A P Marquardt; B L Wood; O Williams; S J Cotler; S L Taylor; R L Carithers; D R Gretch
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 5.  Epidemiology of hepatitis C: geographic differences and temporal trends.

Authors:  A Wasley; M J Alter
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

6.  Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C.

Authors:  Y Arase; K Ikeda; K Chayama; N Murashima; A Tsubota; Y Suzuki; S Saitoh; M Kobayashi; M Kobayashi; F Suzuki; H Kumada
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

7.  Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro.

Authors:  S Iacovacci; A Manzin; S Barca; M Sargiacomo; A Serafino; M B Valli; G Macioce; H J Hassan; A Ponzetto; M Clementi; C Peschle; G Carloni
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

8.  Mutations in hepatitis C virus RNAs conferring cell culture adaptation.

Authors:  V Lohmann; F Körner; A Dobierzewska; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  Terminal nucleotidyl transferase activity of recombinant Flaviviridae RNA-dependent RNA polymerases: implication for viral RNA synthesis.

Authors:  C T Ranjith-Kumar; J Gajewski; L Gutshall; D Maley; R T Sarisky; C C Kao
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

10.  Efficient initiation of HCV RNA replication in cell culture.

Authors:  K J Blight; A A Kolykhalov; C M Rice
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

View more
  35 in total

1.  Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.

Authors:  Naushad Ali; Heba Allam; Randal May; Sripathi M Sureban; Michael S Bronze; Ted Bader; Shahid Umar; Srikant Anant; Courtney W Houchen
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Modeling hepatitis C virus infection using human induced pluripotent stem cells.

Authors:  Robert E Schwartz; Kartik Trehan; Linda Andrus; Timothy P Sheahan; Alexander Ploss; Stephen A Duncan; Charles M Rice; Sangeeta N Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Efficiency of hepatitis C virus infection in vitro.

Authors:  Daniel Favre; Nelson Fausto
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

4.  Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures.

Authors:  Svetlana Marukian; Linda Andrus; Timothy P Sheahan; Christopher T Jones; Edgar D Charles; Alexander Ploss; Charles M Rice; Lynn B Dustin
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

Review 5.  Are all cancer stem cells created equal?

Authors:  Xiujie Xie; Theodoros N Teknos; Quintin Pan
Journal:  Stem Cells Transl Med       Date:  2014-08-13       Impact factor: 6.940

6.  Responses of nontransformed human hepatocytes to conditional expression of full-length hepatitis C virus open reading frame.

Authors:  Weiliang Tang; Catherine A Lázaro; Jean S Campbell; W Tony Parks; Michael G Katze; Nelson Fausto
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

7.  Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication.

Authors:  Steve S Choi; Lee C Claridge; Ravi Jhaveri; Marzena Swiderska-Syn; Paul Clark; Ayako Suzuki; Thiago A Pereira; Zhiyong Mi; Paul C Kuo; Cynthia D Guy; Fausto E L Pereira; Anna Mae Diehl; Keyur Patel; Wing-Kin Syn
Journal:  Clin Sci (Lond)       Date:  2014-06       Impact factor: 6.124

8.  An implantable vascularized protein gel construct that supports human fetal hepatoblast survival and infection by hepatitis C virus in mice.

Authors:  Martha J Harding; Christin M Lepus; Thomas F Gibson; Benjamin R Shepherd; Scott A Gerber; Morven Graham; Frank X Paturzo; Christoph Rahner; Joseph A Madri; Alfred L M Bothwell; Brett D Lindenbach; Jordan S Pober
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

9.  Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs.

Authors:  Saba Khaliq; Shah Jahan; Bushra Ijaz; Waqar Ahmad; Sultan Asad; Asim Pervaiz; Baila Samreen; Mahwish Khan; Sajida Hassan
Journal:  Virol J       Date:  2010-11-13       Impact factor: 4.099

Review 10.  Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse.

Authors:  Jag H Khalsa; Glenn Treisman; Elinore McCance-Katz; Ellen Tedaldi
Journal:  Subst Abus       Date:  2008       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.